Compare UK prices. 40+ products · 22 retailers scored
PeptideClear UK

Research peptide retailer

Maxx Labs

UK research-peptide retailer (trading name of I.H Distributions Ltd, London) with RUO framing and COA/MSDS availability.

Headline price

£3.50 to £89.99

Regulated as

Not disclosed

Delivery area

UK-wide

Certificate of Analysis profile

CoA per batch

Unverified

Access

On request

Lab

Not named

QR-verifiable

No

CoA profile auto-refreshed monthly. See methodology for scoring.

Best for

Best for a named-entity UK retailer with COA + MSDS and card payment

Weak on

Trading history only just past 12 months; HPLC % stated in marketing rather than on the core pages.

What stands out

Our verdict

Clear pass: identifiable London trading entity, correct research-only framing with no therapeutic claims, COA/MSDS availability and GBP card checkout. Recheck HPLC documentation at next review.

Last reviewed 2026-06-03. PeptideClear earns a referral fee when readers click through and convert. Editorial criteria are documented in our methodology.

Ready to start?

Visit Maxx Labs →

Affiliate link. No price difference for you.

Reviewed by Oliver Mackman, editorial director · last reviewed 2026-06-18T12:00:00.000Z
Trust, Legal and Governance

PeptideClear is a trading name of Best Business Loans Ltd, registered in England and Wales (company number 16833937). All services, operations and publications under the PeptideClear brand are delivered by Best Business Loans Ltd.

Legal and Registration

Registered in England and Wales. Company number 16833937. D‑U‑N‑S 234324824. ICO registered, reference ZC151816 (certificate, verify). Registered supplier on the UK Government's Find a Tender Service (FTS). Details publicly available via Companies House and OpenCorporates.

Standards and Governance

Operates under UK data protection and consumer standards. Aligns with UK GDPR, ISO 27001 and ISO 9001 principles. Working towards Cyber Essentials certification.

Domain Continuity

Primary domain peptideclear.co.uk. Business ownership, entity and services remain unchanged. Reviewed quarterly.